List of patent terms extended under 35 USC § 156
List of patent terms extended under 35 USC § 156 - USPTO
The status of each application, including disposition—such as granted, denied, withdrawn, pending—may be determined by reviewing the electronic ...
Patent Term Extension (PTE) Under 35 U.S.C. 156 - USPTO
PTE under 35 U.S.C. ... The right to PTE is the result of the Drug Price Competition and Patent Term Restoration Act of 1984, Public Law 98-417, ...
35 U.S. Code § 156 - Extension of patent term
35 U.S. Code § 156 - Extension of patent term · (i). for not to exceed 5 years from the date of expiration of the original patent term; or · (ii). if the patent ...
35 USC 156 enables the owners of patents on certain human drugs, food or color additives, medical devices, animal drugs, and veterinary biological products to ...
Patent Term Extension under 35 USC § 156 - AIPLA
The term of the patent has not expired before the application for PTE has been submitted (35 U.S.C. §. 156(a)(1)). • The term has never been extended under 156 ...
Patent term extension (PTE) under 35 USC 156 - AIPLA
Part of the 1984 Drug Price Competition and. Patent Term Restoration Act (Hatch-Waxman Act). • Codified as 35 U.S.C. 156. • Mitigates a patent owner's ...
Introduction to Patent Term Extensions (PTE) - Fish & Richardson
[10] See 35 U.S.C. 156(a)(1) and 37 C.F.R. 1.720(g). The statute allows the applicant to request an interim patent term extension under 35 ...
Patent Term Extension - Sterne Kessler
Requirements for PTE Application Under 35 U.S.C. § 156 · The effective date of an Investigational New Drug application (IND) for human drugs.
Page 74 TITLE 35—PATENTS § 156 - GovInfo
112–29, set out as an Effective. Date of 2011 Amendment note under section 2 of this title. § 156. Extension of patent term. (a) The term of a patent which ...
Federal Register/Vol. 87, No. 214/Monday, November 7, 2022/Notices
patent-term-extension/patent-terms- · extended-under-35-usc-156. This list includes the patent application number, patent number, link to the ...
Extension of Patent Term Due to Regulatory Review - eCFR
Interim extension of patent term under 35 U.S.C. 156(e)(2). ... Duty of disclosure in patent term extension proceedings. ... Express withdrawal of application for ...
Patent Term Extension Under 35 U.S.C. § 156 Covers an Active ...
The Federal Circuit affirmed. Section 156 entitles the NDA holder to extend the term of only one patent for the approved product, and limits the scope of that ...
Patent Term Extension under 35 USC §156 - Harness IP
The Scope of Patent Term Extension under 35 USC §156 Only Includes the Active Ingredient of an Approved Product. In Biogen International GmbH ...
37 CFR § 1.790 - Interim extension of patent term under 35 U.S.C. ...
156(g)(1)(B)(ii), (2)(B)(ii), (3)(B)(ii), (4)(B)(ii), or (5)(B)(ii), that began for a product that is the subject of such patent may extend beyond the ...
Patent Term Extension Considerations For Regulated Products
The intent behind Section 156 is to extend patent life to compensate patent holders for patent term lost while developing their product and awaiting US Food ...
Analyses of Section 156 - Extension of patent term, 35 U.S.C. § 156
§ 156 to the United States Patent and Trademark Office (“USPTO”) within the sixty-day period beginning on the same date the product received permission for ...
Establishing Permanent Electronic Filing for Patent Term Extension ...
“Patent Term Extension Application Under 35 U.S.C. 156” (Doc Code TERM.REQ) is the correct document description for a PTE application under 35 ...
Pharmaceutical Patent Term Extension: An Overview - Alacrita
A “timely” application must be filed within 60 days from the date the drug product receives approval after the applicable regulatory review period. For human ...
Patent Term Extensions and the Last Man Standing
See 35 U.S.C. § 156(c)(3) (providing that a patent term plus any extension cannot extend more than fourteen years after FDA approval, thus.
Establishing Permanent Electronic Filing for Patent Term Extension ...
156(d)(1) and 37 CFR 1.740, and “Interim Patent Term Extension Application Under 35 U.S.C. 156(d)(5)” (document code TERM.REQ.ITM) is the ...